Talia Hernandez-Velasco

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

Journal: Leukemia
Published: November 18, 2024

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology
Published: November 05, 2024

CAR-T cell therapy for cancer: current challenges and future directions.

CAR-T cell therapy for cancer: current challenges and future directions.

Journal: Signal transduction and targeted therapy
Published: October 07, 2024

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Blood
Published: May 16, 2024

Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia.

Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia.

Journal: Cell reports
Published: April 16, 2024

Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML.

Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML.

Journal: Leukemia
Published: February 26, 2024

Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.

Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.

Journal: HemaSphere
Published: October 21, 2023

RNA sequestration in P-bodies sustains myeloid leukaemia.

RNA sequestration in P-bodies sustains myeloid leukaemia.

Journal: Nature cell biology
Published: September 18, 2023

NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Journal: Blood
Published: August 14, 2023

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Journal: EMBO molecular medicine
Published: August 05, 2023

Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia.

Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia.

Journal: Translational pediatrics
Published: June 27, 2023

A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

Journal: Blood
Published: April 18, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026